0001437749-18-005723.txt : 20180328
0001437749-18-005723.hdr.sgml : 20180328
20180328170017
ACCESSION NUMBER: 0001437749-18-005723
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180327
FILED AS OF DATE: 20180328
DATE AS OF CHANGE: 20180328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Roshan Hanif A
CENTRAL INDEX KEY: 0001664441
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-20190
FILM NUMBER: 18719552
MAIL ADDRESS:
STREET 1: C/O AEON CLINICAL LABORATORIEXS
STREET 2: 2225 CENTENNIAL DRIVE
CITY: GAINESVILLE
STATE: FL
ZIP: 30504
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aeon Global Health Corp.
CENTRAL INDEX KEY: 0000885074
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 141673067
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 2225 CENTENNIAL DRIVE
CITY: GAINESVILLE
STATE: 2Q
ZIP: 30504
BUSINESS PHONE: 888-661-0225
MAIL ADDRESS:
STREET 1: 2225 CENTENNIAL DRIVE
CITY: GAINESVILLE
STATE: 2Q
ZIP: 30504
FORMER COMPANY:
FORMER CONFORMED NAME: AUTHENTIDATE HOLDING CORP
DATE OF NAME CHANGE: 20010327
FORMER COMPANY:
FORMER CONFORMED NAME: BITWISE DESIGNS INC
DATE OF NAME CHANGE: 19930328
4
1
rdgdoc.xml
FORM 4
X0306
4
2018-03-27
0000885074
Aeon Global Health Corp.
AGHC
0001664441
Roshan Hanif A
AEON GLOBAL HEALTH CORP.
2225 CENTENNIAL DR.
GAINESVILLE
GA
30504
1
1
1
Chairman and CEO
Convertible Note
1.20
2018-03-27
4
A
0
504452
0
A
2018-03-27
2019-03-20
Common Stock
420376
504452
D
Convertible Note
2.03
2018-03-27
4
D
0
255417
0
D
2017-03-20
2018-03-20
Common Stock
125821
0
D
Convertible Note
1.20
2018-03-27
4
A
0
255417
0
A
2018-03-27
2019-03-20
Common Stock
212847
255417
D
Effective on March 27, 2018 the registrant entered into a transaction with the reporting person to exchange a preexisting note originally issued to the reporting person on January 23, 2018 in the aggregate principal amount of $500,000 for a new note in the aggregate principal amount of $504,452 that is convertible into shares of the registrant's common stock. The new note is convertible at the initial conversion rate of $1.20 per share.
Represents the number of shares of common stock issuable upon conversion of the principal amount of the convertible note at the initial conversion price of the convertible note.
The reported transactions involve an amendment of a convertible note originally issued on March 20, 2017 to extend the maturity date and adjust the conversion price, resulting in the deemed cancellation of the old convertible note and the simultaneous issuance of a new convertible note, for purposes of Section 16. The reduction in the conversion price was in consideration of the Reporting Person extending the maturity date of the convertible note.
/s/ Hanif A. Roshan
2018-03-28